Kardiologie up2date 2010; 6(1): 7-10
DOI: 10.1055/s-0029-1244099
Hotline – Herzinsuffizienz

© Georg Thieme Verlag KG Stuttgart · New York

Dilatative Kardiomyopathie und ICD-Therapie

Bernd-Dieter  Gonska
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. März 2010 (online)

Preview

Abstract

One third of the patients with idiopathic dilated cardiomyopathy (IDC) suffer from sudden cardiac death. Risk stratification includes clinical and electrophysiological parameters. Studies published so far concerning sudden cardiac death in IDC do not show a clear advantage of implantable – cardioverter/defibrillator (ICD) – therapy. Only studies concerning „heart failure” patients, including patients with IDC, show a statistically significant advantage of ICD therapy, especially if there is an indication for cardiac resynchronization therapy (CRT).

Literatur

Prof. Dr. B.-D. Gonska

Medizinische Klinik 3 – Kardiologie, Angiologie, Intensivmedizin
St. Vincentius-Kliniken Karlsruhe

Südendstr. 32
76137 Karlsruhe

eMail: kardiologie@vincentius-ka.de